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RNAi takes on DNA
 
NAi may carry out direct silencing not only of RNAs but also 
of DNA, according to new results from Tom Volpe, Shiv 
Grewal, Rob Martienssen, and colleagues (Cold Spring Harbor 
Laboratory (CSHL), Cold Spring Harbor, NY), and Brenda Reinhart 
and David Bartel (Whitehead Institute, Cambridge, MA). Another 
group, led by Kazufumi Mochizuki and Martin Gorovsky 
(University of Rochester, Rochester, NY), has found that similar 
machinery may be used to chop out DNA segments in 
 
Tetrahymena
 
.
Both systems illustrate a solution to a puzzling problem in 
chromatin biology. How can such a wide variety of sequences 
be recognized and directed toward a single fate—either silencing 
in heterochromatin or processing in 
 
Tetrahymena
 
? RNAi may 
provide the answer.
R
 
The story begins with transposons. 
These DNA invaders are characterized 
by little other than their overactive 
transcription from either end, leading 
to complementary transcripts that can 
anneal to each other. The resulting double-
stranded RNA (dsRNA) “is the one thing 
a cell can grab onto,” says Gorovsky. The 
RNAi machinery chops up dsRNAs, and 
the resulting small RNAs target any 
further transcripts for destruction.
Now, the CSHL and Whitehead 
RNAi machinery directs silencing near 
centromeres (top inset) and elimination 
of Tetrahymena sequences.
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groups have found that a similar process may be occurring at the 
repeats flanking the fission yeast centromere. The Whitehead group 
found small RNAs complementary to these repeats, with the CSHL 
group characterizing forward and reverse transcripts and centromere-
localized RNA-dependent RNA polymerase that are probably the 
source of the small RNAs. The CSHL group also found that forward 
transcription, centromeric silencing, and histone modifications 
at the centromere are RNAi dependent. Thus, chromodomain 
proteins may bind the dsRNAs and methylate histone H3, leading 
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apid rerouting of intra-
cellular traffic is respon-
sible for the axon guidance 
of certain fly neurons, 
according to Krystyna 
Keleman, Barry Dickson 
(Research Institute of 
Molecular Pathology, Vienna, 
Austria), and colleagues.
The neurons do not spend 
their whole time crossing and 
recrossing the midline of 
the fly because the midline 
repellent Slit binds the Robo 
receptor. Now, Dickson and 
colleagues show that crossing 
R
 
to recruitment of chromatin silencing proteins such as Swi6.
The proposal in 
 
Tetrahymena
 
 is similar, but here the small 
RNAs are used to mark the chromatin for elimination. Wide-
spread transcripts from one nucleus are matched against the DNA 
of another, and anything left over is characterized as a recent 
invader that should be purged. Gorovsky’s group found small 
RNAs and movement of RNAi machinery between nuclei that 
fits such a model, and a group led by David Allis (University of 
Virginia, Charlottesville, VA) made the connection between 
histone H3 modification and DNA elimination.
Suspicions about a DNA connection are not new—both 
transposons and dsRNA constructed from untranscribed regions 
can cause chromatin changes. But the new work provides a direct 
connection. It does not, however, 
indicate whether RNAi causes silencing 
of noncentromeric heterochromatin. 
Heterochromatin is packed with repeats 
that could yield dsRNA transcripts, 
but worms and plants lacking RNAi 
components, although reported as 
embyronic lethal, have not been examined 
for heterochromatin defects.
A more imponderable question involves 
evolution. Did a system for shutting down 
parasitic transposons get coopted to build 
centromeres, mark 
 
Tetrahymena
 
 sequences for deletion, and stabilize 
repetitive, rearrangement-prone areas of the mammalian genome? 
Or did evolution run that sequence in reverse? Either way, RNAi 
has been a key determinant of genome dynamics.
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events require that the 
guidance protein Comm grab 
onto Robo in the Golgi and 
send it on a suicide journey 
to late endosomes and lyso-
somes. This eliminates the 
influence of Slit, allowing 
neurons to cross. After cross-
ing, Comm is rapidly turned 
off to reestablish Robo signal-
ing and prevent recrossing.
In the few cases studied, 
Comm transcription turns on 
just as neurons initiate their 
turn toward the midline. This 
is probably controlled by cell 
fate determinants that, in turn, are 
determined by the time and place that 
the neuron is born. The shutting down 
of Comm, post-crossing, may be 
controlled by either a midline-derived 
signal or a timing mechanism.
Comm’s activity relies only on a 
minimal sorting motif, so there may well 
be Comm-like proteins in mammals. 
Furthermore, the existence of multiple 
Comm proteins suggest that these 
proteins may take many different victims 
to their deaths. “I guarantee you Comm 
is doing a lot more than sorting Robo 
receptors,” says Dickson.
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Midline crossing 
requires Comm’s 
redirecting of Robo.
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Channeling hedgehogs
 
he Hedgehog (Hh) signaling pathway strikes again. The 
framework of the pathway is simple enough: Hh binds to its 
receptor Patched (Ptc), thus relieving Ptc inhibition of Smoothened 
(Smo) signaling. But now Jussi Taipale, Philip Beachy, and 
colleagues (Johns Hopkins University, Baltimore, MD) have found 
that Ptc may act as a channel.
This is not the first strange episode in Hh biology. Hh looks like 
a bacterial cell wall protein, and uses a bizarre mechanism related to 
that of self-splicing proteins to attach cholesterol to itself. “This 
signaling pathway, which has very profound roles in multicellular 
organisms, was very clearly put together with bits of this and that,” 
says Beachy. “At this point, nothing surprises us.”
Ptc was thought to be a conventional receptor that gripped 
Smo in an inhibitory embrace. But Taipale suspected that the 
original coimmunoprecipitation data were tainted by overexpression 
and the hydrophobicity of Ptc and Smo. “We thought we should 
start from scratch,” he says.
T
Ptc (left) regulates Smo (right) despite their different locations.
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A titinic extension
 
n a homage to reductionism, Hongbin 
Li, Julio Fernandez (Columbia 
University, New York, NY), and 
colleagues show that the properties 
of individual domains of titin, a giant 
muscle protein, can explain the 
elasticity of intact muscle.
The pulling in muscle is done by 
actin and myosin, but stretching is 
resisted by the elasticity of titin. 
Individual titin molecules of up to 
3 MDa span over an entire half 
sarcomere—the unit of contraction 
in muscle. But only one region of titin 
confers elasticity, and this region can 
be broken down into discrete domains.
Fernandez and colleagues stretch 
various combinations of these domains 
by single molecule atomic force 
microscopy. They find that, under 
increasing force, proximal Ig domains 
undergo little passive stretching before 
giving way to a wholesale unfolding. 
I
 
The result is a sawtooth pattern of 
extension, with each peak representing 
the resistance of a single Ig domain.
In contrast, the N2B domain can be 
stretched over a long distance with 
relatively little force. “N2B is behaving 
as a simple entropic spring,” says 
Fernandez. This suggests that N2B does 
not have any significant fixed structural 
elements to resist stretching. “It’s very 
hard to design a protein that will not 
attain some [fixed] three-dimensional 
structure,” said Fernandez. “It’s clearly 
something that is not accidental and 
was meant to be this way.”
The extension of N2B and the similarly 
elastic PEVK domain explains most of 
the elastic behavior of titin. But at higher 
extensions some of the proximal Ig 
domains also unfold. “They serve as a 
gearbox,” says Fernandez. Unfolding 
of an Ig domain creates a longer spring. 
This flexibility may allow muscle to 
operate at various levels of extension 
without the danger of breaking apart 
the sarcomere. Adding this effect to the 
calculations, and multiplying by the 
number of titin molecules present in 
a sarcomere, yields a curve that fits 
the behavior of intact muscle.
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Titin extends first via N2B unravelling 
(smooth curve) before Ig domains 
give way (peaks).
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Taipale failed to find a significant interaction between the two 
proteins, and like others found that the proteins were present 
in different parts of the cell. Furthermore, free Ptc (in excess 
to Smo) affected pathway activity, and substoichiometric Ptc 
(1:45 of Ptc:Smo) resulted in 80% reduction of Smo activity, 
suggesting that Ptc acts catalytically.
Ptc is similar to bacterial proton-driven transporters. Beachy’s 
group found that mutation of two channel-conserved residues 
led to a dramatic defect in Ptc activity. Thus, Hh may block 
Ptc from shipping in a Smo inhibitor or shipping out a Smo 
activator.
The relevant inhibitor or activator is unknown, but it may 
resemble cyclopamine. This steroidal alkaloid was first 
discovered when some Idaho sheep munched a maize lily and 
had malformed cyclopic offspring. The chemical culprit, 
cyclopamine, was isolated. Some thirty years later, Beachy 
found that mice with Hh defects suffered a similar fate, and 
that cyclopamine inhibits Smo.
Beachy has now found that cyclopamine regresses murine 
medulloblastomas, probably because these brain tumors result 
from Hh-dependent proliferation of stem cells. If other similarly 
aggressive but more common tumor types are found to be 
dependent on Hh, then cyclopamine may be the basis for an 
important cancer drug.
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